The evidence of FGF21 concentrations being mostly driven by age and metabolic factors might also explain our finding of similar FGF21 concentrations in NAFLD and cirrhosis, despite tremendous differences in disease severity. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.